Clinical Trial Update: INK Feasibility Study [Phase 3]

View source ↗

Summary

A Phase 3 feasibility trial for INK in procedural sedation was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Procedural Sedation

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Procedural Sedation | Phase 3 | Status: WITHDRAWN